The impact of a pharmacist-led oral anticancer clinic on medication adherence and laboratory monitoring.

Megeed, Ayaa; Magas, Hannah; Accursi, Mallory; Burant, Christopher J; Hansen, Elizabeth

Megeed, Ayaa; Magas, Hannah; Accursi, Mallory; Burant, Christopher J; Hansen, Elizabeth.

Afiliação

Megeed A; Veterans Affairs Central Ohio Healthcare System, Columbus, OH, USA.
Magas H; Veterans Affairs Central Ohio Healthcare System, Columbus, OH, USA.
Accursi M; Veterans Affairs Central Ohio Healthcare System, Columbus, OH, USA.
Burant CJ; Statistical Resource Center at the Geriatric Research, Education & Clinical Center, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA.
Hansen E; Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, USA.

J Oncol Pharm Pract ; 29(8): 1921-1927, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37350157

Assuntos

Antineoplásicos; Farmacêuticos; Humanos; Estudos Retrospectivos; Pandemias; Antineoplásicos/efeitos adversos; Adesão à Medicação

Palavras-chave

MPR; Oral; abiraterone; adherence; anticancer; enzalutamide; ibrutinib; lab monitoring; pharmacist-led clinic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacêuticos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google